A groundbreaking treatment for Alzheimer’s disease may benefit whites more than Black Americans. The treatment works by removing a toxic protein called beta amyloid from the brain, but Black Americans’ disease may be driven by other factors. The new drugs are the first to offer real hope of slowing the fatal disease for the 6.5 million Americans living with Alzheimer’s. Although older Black Americans have twice the rate of dementia as whites, reports indicate they were screened out of clinical trials of the drugs at a higher rate. What age-related illness or problem do you worry most about?